MedTrace Logo

Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies

NCT04051567 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 425

Last updated 2019-10-29

No results posted yet for this study

Summary

Twin pregnancies are associated with increased risk of perinatal adverse outcomes , including preeclampsia , fetal growth restriction , preterm premature rupture of membranes and preterm birth. Low-dose aspirin was recommend by American College of Obstetricians and Gynecologists (ACOG) during pregnancy. In this trial, the investigators suppose that aspirin used in twin-pregnancies could improve adverse pregnancy outcomes.

Conditions

Interventions

DRUG

Aspirin 100mg

In LDA group, patients were asked for taking 100mg aspirin per night;

Sponsors & Collaborators

  • Peking University Third Hospital

    collaborator OTHER

  • Chongqing Medical Center for Women and Children

    collaborator OTHER

  • Ministry of Science and Technology of the People´s Republic of China

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2020-06-01
Completion
2020-12-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04051567 on ClinicalTrials.gov